Armata Pharmaceuticals, Inc.
13 clinical trials · Sponsor
◉ Watch Armata Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection (NCT05616221) | Armata Pharmaceuticals, Inc. | 2023-01-10 |
| Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia (NCT05184764) | Armata Pharmaceuticals, Inc. | 2022-04-26 |
| Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis (NCT04596319) | Armata Pharmaceuticals, Inc. | 2020-12-22 |
Track Armata Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.